These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 11699327)
61. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy. Bilici M; Cakirbay H; Koroglu MA; Guler M; Tosun M; Aydin T; Tan U Int J Neurosci; 2001 Sep; 110(1-2):9-23. PubMed ID: 11697214 [TBL] [Abstract][Full Text] [Related]
62. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment. Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY Cells; 2019 Jun; 8(7):. PubMed ID: 31252530 [TBL] [Abstract][Full Text] [Related]
63. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder. Hung YY; Lin CC; Kang HY; Huang TL Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899 [TBL] [Abstract][Full Text] [Related]
64. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients. Yoon HS; Hattori K; Sasayama D; Kunugi H J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339 [TBL] [Abstract][Full Text] [Related]
66. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy. Bilici M; Koroglu MA; Cakirbay H; Guler M; Tosun M; Aydin T; Tan U Int J Neurosci; 2001 Aug; 109(3-4):149-64. PubMed ID: 11699327 [TBL] [Abstract][Full Text] [Related]